A.R.T. Advisors’s Pacific Biosciences PACB Stock Holding History

A.R.T. Advisors’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-192,196	Closed	-$394K	–	1682
2018 Q1	$394K	Buy	192,196 +111,468	+138%	+$289K	0.02%	1046
2017 Q4	$213K	Buy	+80,728	New	+$283K	0.01%	1142
2017 Q3	–	Sell	-94,339	Closed	-$335K	–	1573
2017 Q2	$335K	Sell	94,339 -75,061	-44%	-$303K	0.02%	967
2017 Q1	$875K	Buy	+169,400	New	+$829K	0.04%	607
2016 Q1	–	Sell	-20,519	Closed	-$269K	–	1580
2015 Q4	$269K	Buy	20,519 +4,050	+25%	+$36.3K	0.01%	1095
2015 Q3	$60K	Sell	16,469 -85,034	-84%	-$416K	﹤0.01%	1278
2015 Q2	$584K	Buy	101,503 +55,690	+122%	+$322K	0.02%	935
2015 Q1	$267K	Sell	45,813 -33,243	-42%	-$229K	0.01%	1150
2014 Q4	$619K	Buy	+79,056	New	+$506K	0.02%	841

Other funds holding PACB

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

A.R.T. Advisors's PACB Position: Q2 2018 in Review

A.R.T. Advisors sold out of Pacific Biosciences (PACB) in Q2 2018, closing a stake of 192,196 shares — an estimated $394K sold.

A.R.T. Advisors first reported a position in PACB in Q4 2014 and held it in 9 quarters. The position peaked at $875K in Q1 2017. 99 funds tracked by Wall St. Rank hold PACB as of Q2 2018.

A.R.T. Advisors reported no remaining Pacific Biosciences position as of Q2 2018 after selling out during the quarter.
A.R.T. Advisors sold 192,196 Pacific Biosciences shares in Q2 2018, an estimated $394K.
A.R.T. Advisors first reported a position in Pacific Biosciences in Q4 2014 and held it in 9 quarters.
A.R.T. Advisors's Pacific Biosciences position peaked at $875K in Q1 2017.
99 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2018.

Based on A.R.T. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.